Advances in Hematology
Overview
Advances in Hematology is a scientific journal, published by Wiley since 2008 in English. The journal's country of origin is United States and its primary focus area is hematology.
Details
Details
Abbr.
Adv Hematol
Publisher
Wiley
Start
2008
End
Continuing
p-ISSN
1687-9104
e-ISSN
1687-9112
Country
United States
Language
English
Specialty
Hematology
Metrics
Metrics
h-index / Ranks: 9030
38
SJR / Ranks: 8161
553
CiteScore / Ranks: 7633
3.50
Recent Articles
11.
Agena A, Mirghani L, Ali Mude A
Adv Hematol
. 2024 Apr;
2024:1766578.
PMID: 38665768
Background: The lack of preceding research in Sudan emphasizes the importance of this study, which contributes critical data to the global understanding of sleep-related health effects. This study investigates the...
12.
Tirago D, Yemane T, Tadasa E
Adv Hematol
. 2024 Apr;
2024:8163447.
PMID: 38655566
Background: Thrombocytopenia is the second most common hematological disorder in pregnancy after anemia worldwide and affects 7-8% of all pregnancies. Pregnant women with thrombocytopenia have complications of excessive bleeding during...
13.
Moshi B, Philipo E, Kileo N, Matobo J, Yondu E, Ikunda D, et al.
Adv Hematol
. 2024 Mar;
2024:7950925.
PMID: 38533292
Sickle cell disease (SCD) is an inherited blood disorder that leads to a variety of complications, including stroke. The use of hydroxyurea (HU) is reported to lessen the frequency and...
14.
Rwezaula S, Yonazi M, Panchal A, Dhoot A, Mathew J, Tony S, et al.
Adv Hematol
. 2024 Mar;
2024:1937419.
PMID: 38524403
Introduction: Due to the significant resources involved in creating HSCT programs there is a significant disparity in the availability of this treatment modality between the developed and developing countries. This...
15.
Zheng R, Solomon A, DiLorenzo M, Rajendran I, Park J, Dhongade V, et al.
Adv Hematol
. 2024 Mar;
2024:8838308.
PMID: 38500844
Venous thromboembolism (VTE) risk is increased in patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). A key question was whether increased intensity of anticoagulation would help prevent VTE...
16.
Chatzidavid S, Kontandreopoulou C, Giannakopoulou N, Diamantopoulos P, Stafylidis C, Kyrtsonis M, et al.
Adv Hematol
. 2024 Mar;
2024:1370364.
PMID: 38435839
Epigenetic regulation has been thoroughly investigated in recent years and has emerged as an important aspect of chronic lymphocytic leukemia (CLL) biology. Characteristic aberrant features such as methylation patterns and...
17.
Almanaseer A, Chin-Yee B, Ho J, Lazo-Langner A, Schenkel L, Bhai P, et al.
Adv Hematol
. 2024 Feb;
2024:3056216.
PMID: 38375212
Background: Thrombocytosis is a common reason for referral to Hematology. Differentiating between secondary causes of thrombocytosis and essential thrombocythemia (ET) is often clinically challenging. A practical diagnostic approach to identify...
18.
Gichuru W, Abinya N, Odhiambo A, Otieno F, Harrison S, Ongondi M
Adv Hematol
. 2024 Feb;
2024:3208717.
PMID: 38375211
Background: Multiple myeloma (MM) is a chronic B-cell malignancy that involves proliferation of neoplastic clonal plasma cells in the bone marrow with circulating monoclonal immunoglobulins or constituent chains in serum...
19.
Hashimoto Y, Omura H, Tanaka T
Adv Hematol
. 2024 Feb;
2024:9591497.
PMID: 38362014
Chronic kidney disease (CKD) is an important risk factor for cardiovascular disease, thrombosis, and all-cause death. However, few studies have examined the association between CKD and the prognosis of patients...
20.
Seck M, Dabo M, Bousso E, Keita M, Toure S, Gueye S, et al.
Adv Hematol
. 2024 Feb;
2024:7501577.
PMID: 38356903
Objectives: The aim of this study was to describe the morbidity and mortality of homozygous sickle cell disease after the age of 40. Methods: This was a cohort study of...